Cardiovascular Pharmacogenomics & Drug Delivery

Covers targeted drug design, genetic response variations, and novel drug delivery vehicles.

Sub-topics:

• CYP2C19 genotype-guided antiplatelet therapy following percutaneous coronary intervention

• Nanoparticle and lipid nanoparticle (LNP) delivery platforms for targeted cardiac gene therapy

• Adverse drug-drug interactions in multi-morbid elderly cardiovascular patients